Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 348.20%1.64M | -41.18%365.95K | 361.01%622.11K | -9.67%134.94K | 89.23%149.39K | -34.27%78.95K | -81.72%120.11K | -50.74%657.13K | 122.04%1.33M | 3,087.53%600.75K |
| Revenue from customers | -68.39%115.53K | 1,119.20%365.49K | -69.28%29.98K | -34.67%97.6K | 89.23%149.39K | -34.27%78.95K | -52.07%120.11K | -62.00%250.56K | 9.76%659.38K | 3,087.53%600.75K |
| Income from government grants | --1.51M | ---- | 1,485.61%592.13K | --37.34K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | 3,922.69%18.26K | --454 | ---- | ---- | ---- | ---- | ---- | -39.73%406.57K | --674.53K | ---- |
| Cash paid | 14.74%-3.66M | -171.54%-4.29M | 41.50%-1.58M | 14.16%-2.7M | -116.26%-3.15M | -11.70%-1.45M | 40.71%-1.3M | 52.81%-2.2M | -3.73%-4.65M | -408.83%-4.49M |
| Payments to suppliers for goods and services | 14.74%-3.66M | -171.54%-4.29M | 41.50%-1.58M | 14.16%-2.7M | -116.26%-3.15M | -11.70%-1.45M | 40.71%-1.3M | 52.81%-2.2M | -3.73%-4.65M | -408.83%-4.49M |
| Direct interest paid | 79.81%-4.59K | ---22.74K | ---- | -206.89%-2.99K | ---973 | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | -96.38%2.61K | 2,440.67%72.03K | 1,218.60%2.84K | -95.89%215 | 169.85%5.24K | -3.00%1.94K | -19.68%2K | -92.36%2.49K | -64.99%32.59K | --93.09K |
| Operating cash flow | 47.89%-2.02M | -305.84%-3.87M | 62.83%-954.47K | 14.17%-2.57M | -117.81%-2.99M | -16.41%-1.37M | 23.20%-1.18M | 53.25%-1.54M | 13.33%-3.29M | -339.16%-3.79M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 98.31%-10K | 32.94%-592.15K | -261.92%-883K | 10.45%-243.98K | -77.28%-272.45K | -153.68K | -24,006.96%-2.88M | 97.60%-11.94K | -2,419.79%-498.67K | |
| Capital expenditure reported | ---10K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | ---- | ---16.65K | ---- | 50.22%-7.34K | ---14.75K | ---- | ---- | 106.99%835 | 84.29%-11.94K | -284.23%-76.04K |
| Net intangibles purchas and sale | ---- | ---- | ---- | 21.58%-236.64K | ---301.76K | ---- | ---- | ---- | ---- | ---470.19K |
| Net business purchase and sale | ---- | --4.45K | ---- | ---- | ---250.53K | ---- | ---- | ---- | ---- | --47.57K |
| Net investment purchase and sale | ---- | ---- | ---389.5K | ---- | 291.68%294.58K | ---153.68K | ---- | ---2.88M | ---- | ---- |
| Net other investing changes | ---- | -17.52%-579.96K | ---493.5K | ---- | ---- | ---- | ---- | ---- | ---89.66K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 98.31%-10K | 32.94%-592.15K | -261.92%-883K | 10.45%-243.98K | -77.28%-272.45K | ---153.68K | ---- | -24,006.96%-2.88M | 97.60%-11.94K | -2,419.79%-498.67K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 492.12%2.01M | -108.11%-512.47K | 6.32M | 405.15%6.66M | 1.32M | 119.51%3.35M | -82.12%1.53M | 829.15%8.55M | ||
| Net issuance payments of debt | --0 | -113.70%-821.73K | --6M | ---- | --2.08M | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | 549.77%2.01M | -3.74%309.26K | --321.27K | ---- | 247.12%4.57M | --1.32M | ---- | 119.51%3.35M | -82.12%1.53M | 481.47%8.55M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --600 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 492.12%2.01M | -108.11%-512.47K | --6.32M | ---- | 405.15%6.66M | --1.32M | ---- | 119.51%3.35M | -82.12%1.53M | 829.15%8.55M |
| Net cash flow | ||||||||||
| Beginning cash position | -96.92%158.35K | 686.91%5.14M | -81.16%652.75K | 4,672.82%3.46M | -74.28%72.59K | -80.70%282.18K | -42.06%1.46M | -41.23%2.52M | 11,586.93%4.29M | --36.74K |
| Current changes in cash | 99.62%-19.09K | -211.03%-4.98M | 259.46%4.48M | -182.90%-2.81M | 1,718.41%3.39M | 82.24%-209.59K | -11.16%-1.18M | 40.04%-1.06M | -141.59%-1.77M | 11,486.93%4.26M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | --1.46M | ---- | ---- | ---- |
| End cash Position | -12.06%139.26K | -96.92%158.35K | 686.91%5.14M | -81.16%652.75K | 4,672.82%3.46M | -74.28%72.59K | -80.70%282.18K | -42.06%1.46M | -41.23%2.52M | 11,586.93%4.29M |
| Free cash from | 47.85%-2.03M | -307.58%-3.89M | 66.06%-954.47K | 15.01%-2.81M | -140.85%-3.31M | -16.41%-1.37M | 23.20%-1.18M | 53.42%-1.54M | 23.97%-3.3M | -391.16%-4.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |